Glucocorticoid-induced osteoporosis
glucocorticoid-induced-osteoporosis · society: ACR
Summary
ACR 2017 update on prevention and treatment of glucocorticoid-induced osteoporosis (GIOP) in adults and children on prednisone ≥2.5 mg/day for ≥3 months. Uses GRADE methodology and FRAX-based (GC-adjusted) fracture risk stratification to guide therapy, with oral bisphosphonates as preferred first-line agents in most moderate-to-high risk patients. Addresses special populations including children, organ transplant recipients, women of childbearing potential, and patients on very high-dose GCs.
Current guideline: ACR 2017 GIOP Guideline · 
download Anki sub-deck
Versions
- 2017 · ACR — ACR 2017 GIOP Guideline